http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101880217-B
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1e74277852f1aae0a3ff13f59a65456d |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C35-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C29-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-047 |
filingDate | 2010-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2014-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0a1541467bfb756beb77ff690c2a542 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f152da55ab3a98de2a21e9777248ff52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ebea9cea8b3555c663cff122a32c2e5 |
publicationDate | 2014-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-101880217-B |
titleOfInvention | Medicinal composition for treating immunological diseases, preparation and application thereof |
abstract | The invention relates to a technical method for preparing kirenol serving as medicinal active ingredients of an immunosuppressant for treating autoimmune diseases and preventing organ transplant rejection and a preparation. The preparation comprises kirenol serving as the medicinal active ingredients and relevant preparations. The kirenol is prepared by adopting a specific method of the invention, and has the advantages of convenient operation, low production cost, low environmental pollution, high-purity prepared kirenol and high yield, wherein the purity of the prepared kirenol reaches over 98 percent. The kirenol and the preparation which are prepared by adopting the method provided by the invention have the advantages of excellent stability, safety, reliability, stable quality and obvious treatment effect, and are particularly used for medicaments for treating the autoimmune diseases and preventing the organ transplant rejection. |
priorityDate | 2009-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 83.